✦ LIBER ✦

Factors mediating against excellence in dental esthetics

✍ Scribed by Richard E. Lombardi

Book ID: 118921644
Publisher: Elsevier Science
Year: 1977
Tongue: English
Weight: 428 KB
Volume: 38
Category: Article
ISSN: 1097-6841
DOI: 10.1016/0022-3913(77)90299-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transforming Growth Factor-??1-Mediated

Transforming Growth Factor-??1-Mediated Neuroprotection Against Excitotoxic Injury in Vivo

✍ Boche, Delphine; Cunningham, Colm; Gauldie, Jack; Perry, V. Hugh 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 610 KB

Hepatocyte growth factor protects agains

Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice

✍ Hideyuki Suzuki; Mitsuo Toyoda; Norio Horiguchi; Satoru Kakizaki; Tatsuya Ohyama 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

Transforming growth factor α protects ag

Transforming growth factor α protects against Fas-mediated liver apoptosis in mice

✍ Daisuke Kanda; Hitoshi Takagi; Mitsuo Toyoda; Norio Horiguchi; Hiroaki Nakajima; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Chlorpromazine protection against interl

Chlorpromazine protection against interleukin-1 and tumor necrosis factor-mediated activities in vivo

✍ Riccardo Bertini; Manuela Mengozzi; Marina Bianchi; Jean D. Sipe; Pietro Ghezzi 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 437 KB

Inhibition of Factor XII-Mediated Activa

Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice

✍ Leung, Philberta Y.; Hurst, Sawan; Berny-Lang, Michelle A.; Verbout, Norah G.; G 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 417 KB

Zoledronic acid protects against local a

Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor–mediated arthritis

✍ Petra Herrak; Birgit Görtz; Silvia Hayer; Kurt Redlich; Erika Reiter; Jürg Gasse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

## Abstract ## Objective Increased osteoclast activity is a key factor in bone loss in rheumatoid arthritis (RA). This suggests that osteoclast‐targeted therapies could effectively prevent skeletal damage in patients with RA. Zoledronic acid (ZA) is one of the most potent agents for blocking osteo